N
Nadia K. Magdalinou
Researcher at UCL Institute of Neurology
Publications - 28
Citations - 2142
Nadia K. Magdalinou is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Progressive supranuclear palsy & Frontotemporal dementia. The author has an hindex of 17, co-authored 27 publications receiving 1574 citations. Previous affiliations of Nadia K. Magdalinou include University College London & University of London.
Papers
More filters
Journal ArticleDOI
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Claire Bridel,van Wieringen Wn,Henrik Zetterberg,Betty M. Tijms,Charlotte E. Teunissen,José C. Álvarez-Cermeño,Ulf Andreasson,Markus Axelsson,David Bäckström,Ales Bartos,Maria Bjerke,Kaj Blennow,Kaj Blennow,A. Boxer,Lena Brundin,Joachim Burman,Tove Christensen,Lenka Fialová,Lars Forsgren,Jette L. Frederiksen,Magnus Gisslén,Elizabeth Gray,Martin Gunnarsson,Sara Hall,Oskar Hansson,Megan K. Herbert,Joel Jakobsson,Jessen-Krut J,Shorena Janelidze,Gudmundur Johannsson,Gudmundur Johannsson,Michael Jonsson,Ludwig Kappos,Mohsen Khademi,Mohsen Khademi,Michael Khalil,Jens Kuhle,Mikael Landén,Leinonen,Giancarlo Logroscino,Lu Ch,Jan Lycke,Nadia K. Magdalinou,Andrea Malaspina,Niklas Mattsson,Lieke H.H. Meeter,Mehta,Signe Modvig,Tomas Olsson,Tomas Olsson,Ross W. Paterson,Pérez-Santiago J,Fredrik Piehl,Fredrik Piehl,Pijnenburg Yal,Pyykkö Ot,Ragnarsson O,Julio C. Rojas,Romme Christensen J,Sandberg L,Carole Scherling,Jonathan M. Schott,Finn Sellebjerg,Isabella Laura Simone,Tobias Skillbäck,Stilund M,Peter Sundström,Anders Svenningsson,Rosanna Tortelli,Carla Tortorella,Alessandro Trentini,Troiano M,Martin R Turner,van Swieten Jc,Mattias Vågberg,Marcel M. Verbeek,Luisa M. Villar,Pieter Jelle Visser,Pieter Jelle Visser,Anders Wallin,Weiss A,Carsten Wikkelsö,Edward J. Wild +82 more
TL;DR: The cNfL increased with age in HC and a majority of neurological conditions, although the association was strongest in HC, and has potential to assist the differentiation of FTD from AD and PD from atypical parkinsonian syndromes.
Journal ArticleDOI
Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
Oskar Hansson,Shorena Janelidze,Sara Hall,Nadia K. Magdalinou,Andrew J. Lees,Ulf Andreasson,Niklas Norgren,Jan Linder,Lars Forsgren,Radu Constantinescu,Henrik Zetterberg,Kaj Blennow +11 more
TL;DR: In this paper, the authors determined if blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease and atypical parkinsonian disorders with equally high diagnostic accuracies.
Journal ArticleDOI
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
Amanda Heslegrave,Wendy E. Heywood,Ross W. Paterson,Nadia K. Magdalinou,Johan Svensson,Per Johansson,Annika Öhrfelt,Kaj Blennow,John Hardy,Jonathan M. Schott,Kevin Mills,Henrik Zetterberg,Henrik Zetterberg +12 more
TL;DR: A mass spectrometry method using selected reaction monitoring for the presence of a TREM2 peptide is developed, which can be used to quantify levels of sTREM2 in CSF, and correlate with markers of neurodegeneration.
Journal ArticleDOI
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
Nadia K. Magdalinou,Ross W. Paterson,Jonathan M. Schott,Nick C. Fox,Catherine J. Mummery,Kaj Blennow,Kailash P. Bhatia,Huw R. Morris,Paola Giunti,Thomas T. Warner,R de Silva,Andrew J. Lees,Henrik Zetterberg +12 more
TL;DR: A panel of nine CSF biomarkers was able to differentiate patients with PD from APS with an area under the curve of 0.95 and subtypes of APS from one another, and may have important clinical utility in improving diagnostic accuracy.
Journal ArticleDOI
Increased CSF neurogranin concentration is specific to Alzheimer disease.
Henrietta Wellington,Ross W. Paterson,Erik Portelius,Ulrika Törnqvist,Nadia K. Magdalinou,Nick C. Fox,Kaj Blennow,Jonathan M. Schott,Henrik Zetterberg +8 more
TL;DR: These results confirm an increase in CSF Ng concentration in patients with AD as previously reported and show that this is specific to AD and not seen in a range of other neurodegenerative diseases.